Recommendations of the Panel on Cost-Effectiveness in Health and Medicine

Cited by (1,004)

Items 501–600 of 1,004

1. The Cost-effectiveness of Adolescent Hepatitis A Vaccination in States With the Highest Disease Rates
   R. Jake Jacobs, Harold S. Margolis, Patrick J. Coleman · 2000 · Archives of Pediatrics and Adolescent Medicine
2. Use of calcium channel blockers and risk of suicide: ecological findings confirmed in population based cohort study
   Gunnar Lindberg, Kerstin Bingefors, Jonas Ranstam, L. Råstam, Arne Melander · 1998 · BMJ
3. Economic evaluation of options for measles vaccination strategy in a hypothetical Western European country
   Philippe Beutels, Nigel J Gay · 2003 · Epidemiology and Infection
4. CT Coronary Angiography in Patients Suspected of Having Coronary Artery Disease: Decision Making from Various Perspectives in the Face of Uncertainty
   Tessa S.S. Genders, Willem Bob Meijboom, Matthijs F.L. Meijs, Joanne Désirée Schuijf, Nico R. Mollet, Annick C. Weustink, Francesca Pugliese, Jeroen Joost Bax, Maarten Jan Cramer, Gabriel Paul Krestin et al. · 2009 · Radiology
5. Early discharge from obstetrics-pediatrics at the Hospital de Valme, with domiciliary follow-up
   José Antonio Sainz‐Bueno, María Ruiz Romano, Rogelio Garrido Teruel, Antonio Gutiérrez Benjumea, Ana Fernández-Palacín, C. Almeida, Manuel Caballero Manzano · 2005 · American Journal of Obstetrics and Gynecology
6. Costs and Benefits of Targeted Screening for Causes of Sudden Cardiac Death in Children and Adolescents
   Laurel K. Leslie, Joshua T. Cohen, Jane W. Newburger, Mark E. Alexander, John B. Wong, Elizabeth D. Sherwin, Angie Mae Rodday, Susan Kenyon Parsons, John K. Triedman · 2012 · Circulation
7. Effectiveness and cost-effectiveness of strategies to expand antiretroviral therapy in St. Petersburg, Russia
   Elisa F Long, Margaret L. Brandeau, Cristina M Galvin, Tatyana Vinichenko, Swati P Tole, Adam Schwartz, Gillian D Sanders, Douglas K Owens · 2006 · AIDS
8. Clinical Effectiveness and Cost-Effectiveness of HIV Pre-Exposure Prophylaxis in Men Who Have Sex with Men: Risk Calculators for Real-World Decision-Making
   Anders Chen, David W. Dowdy · 2014 · PLoS ONE
9. Cost-effectiveness of pegfilgrastim versus 6-day filgrastim primary prophylaxis in patients with non-Hodgkin's lymphoma receiving CHOP-21 in United States
   Gary H. Lyman, Anjana Lalla, Richard L. Barron, Robert W. Dubois · 2008 · Current Medical Research and Opinion
10. The Effect of Budgetary Restrictions on Breast Cancer Diagnostic Decisions
    Mehmet Ayvaci, Oğuzhan Alagöz, Elizabeth S. Burnside · 2012 · Manufacturing & Service Operations Management
11. A preference-based measure of health: the VR-6D derived from the veterans RAND 12-Item Health Survey
    Alfredo J. Selim, William H. Rogers, Shirley X. Qian, John Edward Brazier, Lewis E. Kazis · 2011 · Quality of Life Research
12. How Much Should We Invest In Preventing Childhood Obesity?
    Leonardo Trasande · 2010 · Health Affairs
13. Open versus endoscopic carpal tunnel release: A decision analysis
    Arthur P. Vasen, Karen M. Kuntz, Barry P. Simmons, Jeffrey Neil Katz · 1999 · The Journal Of Hand Surgery
14. Use of B-type natriuretic peptide in the management of acute dyspnea in patients with pulmonary disease
    Christian Eugen Mueller, Kirsten Laule-Kilian, Barbara Frana, Daniel Rodríguez, André Scholer, Christian Schindler, André Paul Perruchoud · 2006 · American Heart Journal
15. Sustainability of Behavioral Interventions: Beyond Cost-Effectiveness Analysis
    Paul Brown, Linda D. Cameron, Steven Ramondt · 2014 · International Journal of Behavioral Medicine
16. EAO consensus conference: economic evaluation of implant‐supported prostheses
    Thomas Beikler, Thomas F. Flemmig · 2015 · Clinical Oral Implants Research
17. The EQ-5D in alcohol dependent patients: Relationships among health-related quality of life, psychopathology and social functioning
    Oliver Günther, Christiane Roick, Matthias C. Angermeyer, Hans‐Helmut König · 2006 · Drug and Alcohol Dependence
18. Cost Effectiveness of Mesh Prophylaxis to Prevent Parastomal Hernia in Patients Undergoing Permanent Colostomy for Rectal Cancer
    Lawrence Lee, Abdulaziz Saleem, Tara Landry, Eric A. Latimer, Prosanto K. Chaudhury, Liane S. Feldman · 2013 · Journal of the American College of Surgeons
19. The clinical burden of prostate cancer in Canada: forecasts from the Montreal Prostate Cancer Model.
    Steven A. Grover, Louis Coupal, Hanna Zowall, Raghu Rajan, John Trachtenberg, MOSTAFA M. ELHILALI, MICHAEL P. CHETNER, Larry Goldenberg · 2000 · Europe PMC (PubMed Central)
20. Cost-effectiveness Analysis of Intraoperative Cell Salvage for Obstetric Hemorrhage
    Grace Lim, Vladyslav Melnyk, Francesca Facco, Jonathan H. Waters, Kenneth J. Smith · 2017 · Anesthesiology
21. Cost-effectiveness Analysis of Anatomic vs Functional Index Testing in Patients With Low-Risk Stable Chest Pain
    Júlia Karády, Thomas Mayrhofer, Alexander V. Ivanov, Borek Foldyna, Michael T. Lu, Maros Ferencik, Amit K. Pursnani, Michael Salerno, James E. Udelson, Daniel B. Mark et al. · 2020 · JAMA Network Open
22. Cystic Fibrosis
    Christian Krauth, N Jalilvand, Tobias Welte, Reinhard Busse · 2003 · PharmacoEconomics
23. Surveillance mammography and stereotactic core breast biopsy for probably benign lesions: A cost comparison analysis
    R. James Brenner, Edward A. Sickles · 1997 · Academic Radiology
24. Cost-effectiveness analysis of tacrolimus ointment versus high-potency topical corticosteroids in adults with moderate to severe atopic dermatitis
    Charles N. Ellis, Lynn A. Drake, Mary M. Prendergast, William Abramovits, Mark Boguniewicz, C. Ralph Daniel, Mark Lebwohl, Amy S. Paller, Seth R. Stevens, Diane L. Whitaker-Worth et al. · 2003 · Journal of the American Academy of Dermatology
25. THE LONG-TERM COST-EFFECTIVENESS OF IMPROVING ALCOHOL ABSTINENCE WITH ADJUVANT ACAMPROSATE
    Andrew John Palmer · 2000 · Alcohol and Alcoholism
26. Economic Opportunities and Challenges for Pharmacogenomics
    Patricia A. Deverka, John A. Vernon, Howard L. McLeod · 2010 · The Annual Review of Pharmacology and Toxicology
27. Cost-Effectiveness Analyses in Orthopaedic Sports Medicine
    Benedict Uchenna Nwachukwu, William W. Schairer, Jaime Lynn Bernstein, Emily R. Dodwell, Robert G. Marx, Answorth A. Allen · 2014 · The American Journal of Sports Medicine
28. Cost utility in the United States of rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone for the treatment of elderly patients with diffuse large B‐cell lymphoma
    John C Hornberger, Jennie H. Best · 2005 · Cancer
29. A comparison of preferences for two GLP-1 products – liraglutide and exenatide – for the treatment of type 2 diabetes
    Michael R. Polster, Elaine L. Zanutto, Susan McDonald, Christopher Conner, Mette Hammer · 2010 · Journal of Medical Economics
30. MRI surveillance of vestibular schwannomas without contrast enhancement: Clinical and economic evaluation
    Daniel H. Coelho, Yang Tang, Brian Suddarth, Mohammed Mamdani · 2017 · The Laryngoscope
31. The full benefits of adult pneumococcal vaccination: A systematic review
    Elizabeth T. Cafiero-Fonseca, Andrew Stawasz, Sydney T. Johnson, Reiko Sato, David E. Bloom · 2017 · PLoS ONE
32. Which Lynch syndrome screening programs could be implemented in the “real world”? A systematic review of economic evaluations
    Marco Di Marco, Elvira D’Andrea, Nikola Panić, Valentina Baccolini, Giuseppe Migliara, Carolina Marzuillo, Corrado De Vito, Roberta Pastorino, Stefania Boccia, Paolo Villari · 2018 · Genetics in Medicine
33. Estimates of the Lifetime Direct Costs of Treatment for Metastatic Breast Cancer
    Noah C. Berkowitz, Sanjay Kumar Gupta, George Silberman · 2000 · Value in Health
34. Cost-effectiveness of Empagliflozin in Patients With Heart Failure With Preserved Ejection Fraction
    Jimmy Zheng, Justin T. Parizo, John A. Spertus, Paul A. Heidenreich, Alexander T. Sandhu · 2022 · JAMA Internal Medicine
35. Partially wrong? Partial equilibrium and the economic analysis of public health emergencies of international concern
    Philippe Beutels, W. John Edmunds, Richard Smith · 2008 · Health Economics
36. Lapatinib plus capecitabine versus capecitabine alone for HER2+ (ErbB2+) metastatic breast cancer: quality-of-life assessment
    Xiaolei Zhou, David F Cella, David Cameron, Mayur Mohan Amonkar, Anthony C. Segreti, Steven Stein, Mel D. Walker, Charles E. Geyer · 2009 · Breast Cancer Research and Treatment
37. Clinical benefit and cost effectiveness of total knee arthroplasty in the older patient
    Frank Krummenauer, C. Wolf, K-P Günther, S. Kirschner · 2009 · European journal of medical research
38. Promoting advance planning for health care and research among older adults: A randomized controlled trial
    Gina Bravo, Marcel Arcand, Danièle Blanchette, Anne‐Marie Boire‐Lavigne, Marie‐France Dubois, Maryse Guay, Paule Hottin, Julie Lane, Judith Lauzon, Suzanne Bellemare · 2012 · BMC Medical Ethics
39. Early Versus Delayed Surgical Decompression of Spinal Cord after Traumatic Cervical Spinal Cord Injury: A Cost-Utility Analysis
    Julio Cesar Furlan, B. Catharine Craven, Eric Maurice Massicotte, Michael George Fehlings · 2016 · World Neurosurgery
40. Impact Of The YMCA Of The USA Diabetes Prevention Program On Medicare Spending And Utilization
    Maria Liliana Alva, Thomas J. Hoerger, Ravikumar Jeyaraman, Peter R. Amico, Lucia Rojas Smith · 2017 · Health Affairs
41. Effectiveness of a Brief Self-determination Theory–Based Smoking Cessation Intervention for Smokers at Emergency Departments in Hong Kong
    W. Li, K. Ho, M. Wang, D. Cheung, K. Lam, W. Xia, Kai-Yeung Cheung, C. Wong, S. Chan, Tai-Hing Lam · 2019 · JAMA Internal Medicine
42. Controvalore economico del farmaco e beneficio clinico: stato dell’arte della metodologia e applicazione di un algoritmo farmacoeconomico
    Andrea Messori, Benedetta Santarlasci, Sabrina Trippoli, Monica Vaiani · 2003 · PharmacoEconomics Italian Research Articles
43. Avoiding Double-Counting in Pharmacoeconomic Studies
    Magnus Johannesson · 1997 · PharmacoEconomics
44. The role of dietary factors in the intestinal and diffuse histologic subtypes of gastric adenocarcinoma
    Lawrence E. Harrison, Zuo‐Feng Zhang, Martin S. Karpeh, Ming Sun, Robert C. Kurtz · 1997 · Cancer
45. Patient and Informal Caregiver Time in Cost-Effectiveness Analysis:A Response to the Recommendations of the Washington Panel
    Werner B. F. Brouwer, Marc A. Koopmanschap, Frans Rutten · 1998 · International Journal of Technology Assessment in Health Care
46. The cost-effectiveness of using chronic kidney disease risk scores to screen for early-stage chronic kidney disease
    on behalf of the Centers for Disease Control and Prevention CKD Initiative, Yarnoff, Benjamin O., Hoerger, Thomas J., Simpson, Siobhan K., Leib, Alyssa, Burrows, Nilka R., Shrestha, Sundar S., Pavkov, Meda E. · 2017 · BMC Nephrology
47. Updating Cost Effectiveness Analyses in Orthopedic Surgery: Resilience of the $50,000 per QALY Threshold
    Benedict Uchenna Nwachukwu, Kevin John Bozic · 2015 · The Journal of Arthroplasty
48. Treatment for life for severe haemophilia A– A cost‐utility model for prophylaxis vs. on‐demand treatment
    Albert Farrugia, Josephine Cassar, Mary Clare Kimber, Megha Bansal, Kathelijn Fischer, G. Auserswald, Brian O’Mahony, Keith H. Tolley, Declan Noone, Sonia Balboni · 2013 · Haemophilia
49. PRIORITIZING PATIENTS FOR ELECTIVE SURGERY
    Sarah Derrett, Nancy J. Devlin, Paul Hansen, Peter Herbison · 2003 · International Journal of Technology Assessment in Health Care
50. The 5-Year Cost-effectiveness of Anterior Cervical Discectomy and Fusion and Cervical Disc Replacement
    Steven J. McAnany, Samuel C. Overley, Evan O. Baird, Samuel Kang-Wook Cho, Andrew C. Hecht, Jack E. Zigler, Sheeraz A. Qureshi · 2014 · Spine
51. Statistical Analysis of Total Labor Pain Using the Visual Analog Scale and Application to Studies of Analgesic Effectiveness During Childbirth
    Elizabeth A. Ludington, Franklin Dexter · 1998 · Anesthesia & Analgesia
52. Comparison of the HUI3 with the SF-36 Preference Based SF-6D in a Clinical Trial Setting
    Hind T. Hatoum, John Edward Brazier, Kasem S. Akhras · 2004 · Value in Health
53. The Cost-Effectiveness of Immunohistochemistry
    Stephen Spencer Raab · 2000 · Archives of Pathology & Laboratory Medicine
54. Regional variation in the cost effectiveness of childhood hepatitis A immunization
    R. Jake Jacobs, David P. Greenberg, Raymond S. Koff, Sammy Saab, Allen S. Meyerhoff · 2003 · The Pediatric Infectious Disease Journal
55. Use of Global Visual Acuity Data in a Time Trade-off Approach to Calculate the Cost Utility of Cataract Surgery
    Van Charles Lansingh · 2009 · Archives of Ophthalmology
56. Total Wrist Arthroplasty and Total Wrist Arthrodesis in Rheumatoid Arthritis: A Decision Analysis From the Hand Surgeons' Perspective
    Christi M. Cavaliere, Kevin C. Chung · 2008 · The Journal Of Hand Surgery
57. Cost-effectiveness of universal childhood hepatitis A vaccination in Chile
    María Teresa Valenzuela, R. Jake Jacobs, Óscar Arteaga, María Soledad Navarrete, Allen S. Meyerhoff, Bruce L. Innis · 2005 · Vaccine
58. Cost‐effectiveness of nurse practitioner management of hypercholesterolemia following coronary revascularization
    Kathryn Paez, Jerilyn K. Allen · 2006 · Journal of the American Academy of Nurse Practitioners
59. The Cost-Effectiveness of Three Screening Alternatives for People with Diabetes with No or Early Diabetic Retinopathy
    David B. Rein, John S. Wittenborn, Xinzhi Zhang, Benjamin T. Allaire, Michael S. Song, Ronald Klein, JINAN B. SAADDINE, for the Vision Cost-Effectiveness Study Group · 2011 · Health Services Research
60. A Cost-Utility Analysis of Neonatal Circumcision
    Robert S. Van Howe · 2004 · Medical Decision Making
61. Cost-effectiveness of Hepatitis B Virus Infection Screening and Treatment or Vaccination in 6 High-risk Populations in the United States
    Harinder Singh Chahal, Marion G. Peters, Aaron M. Harris, Devon McCabe, Paul A. Volberding, James G. Kahn · 2018 · Open Forum Infectious Diseases
62. Cost-Effectiveness of Dual-Chamber Pacing Compared With Ventricular Pacing for Sinus Node Dysfunction
    Stéphane Rinfret, David J. Cohen, Gervasio A. Lamas, Kirsten E. Fleischmann, Milton C. Weinstein, Endel John Orav, ELEANOR B. SCHRON, Kerry L. Lee, Lee Goldman · 2005 · Circulation
63. The Management of Small Polyps Found by Virtual Colonoscopy: Results of a Decision Analysis
    Chin Hur, Daniel C. Chung, Robert E. Schoen, G. Scott Gazelle · 2007 · Clinical Gastroenterology and Hepatology
64. The Importance of Indirect Costs in Primary Cardiovascular Disease Prevention
    Steven A. Grover, Vivian Ho, Frédéric Lavoie, Louis Coupal, Hanna Zowall, Louise Pilote · 2003 · Archives of Internal Medicine
65. Hepatic Resection for Colorectal Liver Metastases: A Cost-Effectiveness Analysis
    Stephen M. Beard, Michael Holmes, Charles C. Price, Ali W. Majeed · 2000 · Annals of Surgery
66. Budget Impact and Sustainability of Medical Care Management for Persons With Serious Mental Illnesses
    Benjamin G. Druss, Silke A. von Esenwein, Michael T. Compton, Liping Zhao, DOUGLAS L. LESLIE · 2011 · American Journal of Psychiatry
67. The cost-effectiveness of expanded HIV screening in the United States
    Aaron Lucas, Benjamin Armbruster · 2012 · AIDS
68. A cost-effectiveness analysis of a community pharmacist-based smoking cessation programme in Thailand
    Kednapa Thavorn, Nathorn Chaiyakunapruk · 2008 · Tobacco Control
69. Cost-utility analysis of the use of prophylactic mesh augmentation compared with primary fascial suture repair in patients at high risk for incisional hernia
    John Patrick Fischer, Marten N. Basta, Jason D. Wink, Naveen M. Krishnan, Stephen J. Kovach · 2015 · Surgery
70. Metastatic Colorectal Carcinoma: Cost-effectiveness of Percutaneous Radiofrequency Ablation versus That of Hepatic Resection
    G. Scott Gazelle, Pamela M. McMahon, Molly T. Beinfeld, Elkan F. Halpern, Milton C. Weinstein · 2004 · Radiology
71. Future costs in cost effectiveness analysis
    Robert H. Lee · 2008 · Journal of Health Economics
72. Routine Pediatric Enterovirus 71 Vaccination in China: a Cost-Effectiveness Analysis
    Joseph Tsz Kei Wu, Mark Jit, Yaming Zheng, Kathy S. M. Leung, Weijia Xing, Juan Yang, Qiaohong Liao, Benjamin John Cowling, Bingyi Yang, Eric H. Y. Lau et al. · 2016 · PLoS Medicine
73. Cost-Effectiveness of Bariatric Surgery Prior to Total Knee Arthroplasty in the Morbidly Obese
    Alexander S. McLawhorn, Daniel L. Southren, Y. Claire Wang, Robert G. Marx, Emily R. Dodwell · 2016 · Journal of Bone and Joint Surgery
74. Cost-effectiveness of pembrolizumab versus docetaxel for the treatment of previously treated PD-L1 positive advanced NSCLC patients in the United States
    Min Huang, Yanyan Lou, James M. Pellissier, Thomas A. Burke, Frank Xiaoqing Liu, Ruifeng Xu, Vamsidhar Velcheti · 2016 · Journal of Medical Economics
75. Future Costs in Cost-Effectiveness Analyses: Past, Present, Future
    Linda M. de Vries, Pieter H M van Baal, Werner B. F. Brouwer · 2018 · PharmacoEconomics
76. Optimizing Choledocholithiasis Management
    Benjamin K. Poulose · 2007 · Archives of Surgery
77. Coronary artery disease and outcome in acute congestive heart failure
    L Purek, K Laule-Kilian, A Christ, T Klima, M E Pfisterer, A P Perruchoud, C Mueller · 2005 · Heart
78. The Generalisability of Pharmacoeconomic Studies
    James M. Mason · 1997 · PharmacoEconomics
79. Cost-effectiveness Analysis of Bariatric Surgery for Patients With Nonalcoholic Steatohepatitis Cirrhosis
    Matthew J. Klebanoff, Kathleen E. Corey, Sumeyye Samur, Jin Choi, Lee M. Kaplan, Jagpreet Chhatwal, Chin Hur · 2019 · JAMA Network Open
80. Cost-Effectiveness of Primary versus Secondary Prophylaxis with Pegfilgrastim in Women with Early-Stage Breast Cancer Receiving Chemotherapy
    Scott D. Ramsey, Zhimei Liu, Rob Boer, Sean D. Sullivan, Jennifer L. Malin, Quan V. Doan, Robert W. Dubois, Gary H. Lyman · 2008 · Value in Health
81. Impact of treatment completion, intolerance and adverse events on health system costs in a randomised trial of 4 months rifampin or 9 months isoniazid for latent TB
    Anne Aspler, Richard Long, Anete Trajman, Marie-Josée Dion, Kamran Khan, Kevin Schwartzman, Dick Menzies · 2010 · Thorax
82. Hospital Cost Analysis of a Prospective, Randomized Trial of Early vs Interval Appendectomy for Perforated Appendicitis in Children
    Adrianne L. Myers, Regan Frances Williams, Kim Giles, Teresa M. Waters, James W. Eubanks, Douglas S. Hixson, Eunice Y. Huang, Max Raymond Langham, Martin L. Blakely · 2012 · Journal of the American College of Surgeons
83. The Cost-Effectiveness of Anterior Cruciate Ligament Reconstruction in Competitive Athletes
    Bruce A. Stewart, Amit Mukesh Momaya, Marc D. Silverstein, David M. Lintner · 2016 · The American Journal of Sports Medicine
84. The cost-effectiveness of bike lanes in New York City
    Jing Gu, Babak Mohit, Peter Alexander Muennig · 2016 · Injury Prevention
85. The Impact of Patient Preferences on the Cost-Effectiveness of Intensive Glucose Control in Older Patients With New-Onset Diabetes
    Elbert S. Huang, Morgan E. Shook, Lei Jin, Marshall H. Chin, David O. Meltzer · 2006 · Diabetes Care
86. Utilities Should Not Be Multiplied
    Alex Z. Fu, Michael W. Kattan · 2008 · Medical Care
87. Cost analysis of alternative approaches to colorectal screening in familial adenomatous polyposis
    David M. Cromwell, ‡ Richard D. Moore, Jill D. Brensinger, Gloria M. Petersen, Eric B Bass, Francis M. Giardiello*,∥ · 1998 · Gastroenterology
88. Cost‐Effectiveness of the Diagnostic Evaluation of Vertigo
    Michael G. Stewart, Amy Y. Chen, J. Robert Wyatt, Favrot, Sean C. Beinart, Newton J. Coker, Herman Arthur Jenkins · 1999 · The Laryngoscope
89. The Cost-Effectiveness of Nonsurgical Versus Surgical Treatment for Carpal Tunnel Syndrome
    Jay Pomerance, David Zurakowski, Ilene Fine · 2009 · The Journal Of Hand Surgery
90. Health-related quality of life, utility, and productivity outcomes instruments: ease of completion by subjects with COPD.
    Elisabeth Ståhl, Sven‐Arne Jansson, Ann-Christin Jonsson, Klas Svensson, Bo Lundbäck, Fredrik Andersson · 2003 · Health and Quality of Life Outcomes
91. Management of End-Stage Ankle Arthritis: Cost-Utility Analysis Using Direct and Indirect Costs
    Benedict Uchenna Nwachukwu, Alexander S. McLawhorn, Matthew S Simon, Kamran S. Hamid, Constantine A. Demetracopoulos, Jonathan Thorndike Deland, Scott Jacob Ellis · 2015 · Journal of Bone and Joint Surgery
92. Cost analysis of magnetically controlled growing rods compared with traditional growing rods for early-onset scoliosis in the US: an integrated health care delivery system perspective
    Stacey J. Ackerman, David W. Polly, Behrooz A. Akbarnia, Jeff Pawelek, Karen Schneider · 2016 · ClinicoEconomics and Outcomes Research
93. A Cost Utility Analysis of Interdisciplinary Early Intervention Versus Treatment as Usual For High-Risk Acute Low Back Pain Patients
    Mark D. Rogerson, Robert J. Gatchel, Samuel Michael Bierner · 2010 · Pain Practice
94. Epidemiological modelling of routine use of low dose aspirin for the primary prevention of coronary heart disease and stroke in those aged ≥70
    Mark Raymond Nelson, Danny Liew, Melanie Bertram, Theo Vos · 2005 · BMJ
95. Statistical Analysis of Total Labor Pain Using the Visual Analog Scale and Application to Studies of Analgesic Effectiveness During Childbirth
    Elizabeth A. Ludington, Franklin Dexter · 1998 · Anesthesia & Analgesia
96. Cost–Effectiveness of Ursodeoxycholic Acid Therapy in Primary Biliary Cirrhosis
    Tousif M. Pasha, Jenny Heathcote, Sherine E. Gabriel, Karen Cauch‐Dudek, Roberta A. Jorgensen, Terry M. Therneau, Rolland E. Dickson, Keith D. Lindor · 1999 · Hepatology
97. MADIT II (Second Multicenter Automated Defibrillator Implantation Trial) Debate
    Matthew R. Reynolds, Mark E. Josephson · 2003 · Circulation
98. Economic evaluation of galantamine in the treatment of mild to moderate Alzheimer's disease in the United States
    Kristen Migliaccio–Walle, Denis Getsios, J. Jaime, K. Jack Ishak, Judith A. O’Brien, George Papadopoulos · 2003 · Clinical Therapeutics
99. Indirect costs associated with metastatic breast cancer
    Yin Wan, Xin Yuan Gao, Sonam Mehta, Zhixiao Wang, Claudio Faria, Lee Steven Schwartzberg · 2013 · Journal of Medical Economics
100. Pharmacoeconomic Implications of New Therapies in Sepsis
     Kelly A Wood, Derek C. Angus · 2004 · PharmacoEconomics